These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38322258)
1. A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus. Wang Y; Liu S; Li B; Sun X; Pan Q; Zheng Y; Liu J; Zhao Y; Wang J; Liu L; Du E Front Immunol; 2024; 15():1336239. PubMed ID: 38322258 [TBL] [Abstract][Full Text] [Related]
2. In vivo oral administration effects of various oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to pseudorabies attenuated virus vaccine in newborn piglets. Linghua Z; Xingshan T; Fengzhen Z Vaccine; 2008 Jan; 26(2):224-33. PubMed ID: 18063448 [TBL] [Abstract][Full Text] [Related]
3. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides. Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y Front Immunol; 2018; 9():783. PubMed ID: 29720976 [TBL] [Abstract][Full Text] [Related]
4. Efficient priming of CD4 T cells by Langerin-expressing dendritic cells targeted with porcine epidemic diarrhea virus spike protein domains in pigs. Subramaniam S; Cao D; Tian D; Cao QM; Overend C; Yugo DM; Matzinger SR; Rogers AJ; Heffron CL; Catanzaro N; Kenney SP; Opriessnig T; Huang YW; Labarque G; Wu SQ; Meng XJ Virus Res; 2017 Jan; 227():212-219. PubMed ID: 27784629 [TBL] [Abstract][Full Text] [Related]
5. Recombinant E Wang S; Yang G; Nie J; Yang R; Du M; Su J; Wang J; Wang J; Zhu Y Vaccine; 2020 May; 38(22):3881-3891. PubMed ID: 32280039 [TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides. Yu C; An M; Li M; Liu H Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus. Guo W; Wang C; Song X; Xu H; Zhao S; Gu J; Zou Z; Li J; Qian J; Zhang X; Guo R; Li J; Li L; Hu Z; Ren L; Fan B; Li B Vaccine; 2024 Feb; 42(4):828-839. PubMed ID: 38220489 [TBL] [Abstract][Full Text] [Related]
8. Development of a subunit vaccine containing recombinant Riemerella anatipestifer outer membrane protein A and CpG ODN adjuvant. Chu CY; Liu CH; Liou JJ; Lee JW; Cheng LT Vaccine; 2015 Jan; 33(1):92-9. PubMed ID: 25448104 [TBL] [Abstract][Full Text] [Related]
9. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets. Linghua Z; Xingshan T; Fengzhen Z Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828 [TBL] [Abstract][Full Text] [Related]
10. CpG ODN 2102 promotes antibacterial immune responses and enhances vaccine-induced protection in golden pompano (Trachinotusovatus). Chen X; Wu Y; Qiu Y; Li P; Cao Z; Zhou Y; Sun Y Fish Shellfish Immunol; 2023 Jun; 137():108783. PubMed ID: 37137380 [TBL] [Abstract][Full Text] [Related]
11. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo. Zhang L; Tian X; Zhou F Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683 [TBL] [Abstract][Full Text] [Related]
12. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice. Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014 [TBL] [Abstract][Full Text] [Related]
14. S1 domain of the porcine epidemic diarrhea virus spike protein as a vaccine antigen. Makadiya N; Brownlie R; van den Hurk J; Berube N; Allan B; Gerdts V; Zakhartchouk A Virol J; 2016 Apr; 13():57. PubMed ID: 27036203 [TBL] [Abstract][Full Text] [Related]
16. Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice. Liu Y; Luo X; Yang C; Yu S; Xu H Vaccine; 2011 Aug; 29(34):5778-84. PubMed ID: 21664398 [TBL] [Abstract][Full Text] [Related]
17. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. Mutwiri G; Benjamin P; Soita H; Babiuk LA Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493 [TBL] [Abstract][Full Text] [Related]
18. MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice. Yang M; Yan Y; Fang M; Wan M; Wu X; Zhang X; Zhao T; Wei H; Song D; Wang L; Yu Y Int Immunopharmacol; 2012 Aug; 13(4):408-16. PubMed ID: 22595192 [TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Kumar S; Jones TR; Oakley MS; Zheng H; Kuppusamy SP; Taye A; Krieg AM; Stowers AW; Kaslow DC; Hoffman SL Infect Immun; 2004 Feb; 72(2):949-57. PubMed ID: 14742540 [TBL] [Abstract][Full Text] [Related]
20. Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice. Wack A; Baudner BC; Hilbert AK; Manini I; Nuti S; Tavarini S; Scheffczik H; Ugozzoli M; Singh M; Kazzaz J; Montomoli E; Del Giudice G; Rappuoli R; O'Hagan DT Vaccine; 2008 Jan; 26(4):552-61. PubMed ID: 18162266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]